Invo Bioscience Stock Story
| INVO Stock | USD 0.82 0.12 12.77% |
About 55% of INVO Bioscience's investors are presently thinking to get in. The analysis of overall sentiment of trading INVO Bioscience stock suggests that some investors are interested at this time. INVO Bioscience's investor sentiment overview provides quick insight into current market opportunities from investing in INVO Bioscience. The current market sentiment, together with INVO Bioscience's historical and current headlines, can help investors time the market. In addition, many technical investors use INVO Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
INVO Bioscience stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of INVO daily returns and investor perception about the current price of INVO Bioscience as well as its diversification or hedging effects on your existing portfolios.
INVO |
Requested story not found. it has been either deleted or moved. View all stories for INVO Bioscience.
INVO Bioscience Latest Timeline
INVO Bioscience is listed for 0.82. The company currently holds 2.66 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies.Check out INVO Bioscience Hype Analysis, INVO Bioscience Correlation and INVO Bioscience Performance. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.34) | Revenue Per Share 2.043 | Quarterly Revenue Growth 3.143 | Return On Assets (0.41) | Return On Equity (10.61) |
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.